BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Aykan NF, Özatlı T. Objective response rate assessment in oncology: Current situation and future expectations. World J Clin Oncol 2020; 11(2): 53-73 [PMID: 32133275 DOI: 10.5306/wjco.v11.i2.53]
URL: https://www.wjgnet.com/1948-5182/full/v11/i2/53.htm
Number Citing Articles
1
Kostas Marias. The Constantly Evolving Role of Medical Image Processing in Oncology: From Traditional Medical Image Processing to Imaging Biomarkers and RadiomicsJournal of Imaging 2021; 7(8): 124 doi: 10.3390/jimaging7080124
2
Konstantinos Vrontis, Sofia C. Economidou, George Fotopoulos. Platinum Doublet plus Atezolizumab as First-line Treatment in Metastatic Large Cell Neuroendocrine Carcinoma: A Single Institution ExperienceCancer Investigation 2022; 40(2): 124 doi: 10.1080/07357907.2021.1988962
3
Yasemin Söyler, Özlem Özmen, Pınar Akın Kabalak, Hakan Ertürk, Feza Uğurman, Ülkü Yılmaz. The efficacy of 18F-FDG PET/CT in monitoring disease progression in malignant pleural mesotheliomaRevista Española de Medicina Nuclear e Imagen Molecular (English Edition) 2023; 42(1): 3 doi: 10.1016/j.remnie.2022.09.005
4
Litao Huang, Deying Kang, Chongyang Zhao, Xueting Liu. Correlation between surrogate endpoints and overall survival in unresectable hepatocellular carcinoma patients treated with immune checkpoint inhibitors: a systematic review and meta-analysisScientific Reports 2024; 14(1) doi: 10.1038/s41598-024-54945-6
5
Thomas Kelleher, Junliang Cai, Nicholas AJ Botwood, Dominic F Labriola. Characterizing tumor shrinkage as a measure of clinical benefit for immune checkpoint inhibitorsJournal for ImmunoTherapy of Cancer 2021; 9(2): e001177 doi: 10.1136/jitc-2020-001177
6
Samantha M. Ruff, Zachary J. Brown, Timothy M. Pawlik. A review of targeted therapy and immune checkpoint inhibitors for metastatic colorectal cancerSurgical Oncology 2023; 51: 101993 doi: 10.1016/j.suronc.2023.101993
7
Inga Trulson, Stefan Holdenrieder, Stefan Holdenrieder, Huub van Rossum, Michel van den Heuvel. Prognostic value of blood-based protein biomarkers in non-small cell lung cancer: A critical review and 2008–2022 updateTumor Biology 2024; 46(s1): S111 doi: 10.3233/TUB-230009
8
Jia Tan, Chang Liu, Yan Li, Yiqi Ma, Ruoxi Xie, Zheng Li, Hengjiang Wan, Su Lui, Min Wu. Assessment of immunotherapy response in intracranial malignancy using semi-automatic segmentation on magnetic resonance imagesFrontiers in Immunology 2022; 13 doi: 10.3389/fimmu.2022.1029656
9
Azadeh Tabari, Brian D’Amore, Janice Noh, Michael S. Gee, Dania Daye. Quantitative peritumoral magnetic resonance imaging fingerprinting improves machine learning-based prediction of overall survival in colorectal cancerExploration of Targeted Anti-tumor Therapy 2024; 5(1): 74 doi: 10.37349/etat.2024.00205
10
Zhaoshi Bao, Shouwei Li, Liang Wang, Bisi Zhang, Peilong Zhang, Hepeng Shi, Xiaoguang Qiu, Tao Jiang. PTPRZ1-METFUsion GENe (ZM-FUGEN) trial: study protocol for a multicentric, randomized, open-label phase II/III trialChinese Neurosurgical Journal 2023; 9(1) doi: 10.1186/s41016-023-00329-0
11
Kwanjoo Lee, Jae Seung Lee, Do Young Kim. Transarterial chemoembolization versus radioembolization as a treatment option for single large (>5 cm) hepatocellular carcinoma: a retrospective study in South KoreaLife Cycle 2023; 3 doi: 10.54724/lc.2023.e13
12
Y. Söyler, Ö. Özmen, P.A. Kabalak, H. Ertürk, F. Uğurman, Ü. Yılmaz. La eficacia de [18F]FDG PET/TC en el seguimiento de la progresión de la enfermedad en el mesotelioma pleural malignoRevista Española de Medicina Nuclear e Imagen Molecular 2023; 42(1): 3 doi: 10.1016/j.remn.2022.06.005
13
Jiayu Wang, Dana Al-Majid, J. Chad Brenner, Joshua D. Smith. Mutant HRas Signaling and Rationale for Use of Farnesyltransferase Inhibitors in Head and Neck Squamous Cell CarcinomaTargeted Oncology 2023; 18(5): 643 doi: 10.1007/s11523-023-00993-3
14
Cinzia Dello Russo, Pierluigi Navarra. Local Investigators Significantly Overestimate Overall Response Rates Compared to Blinded Independent Central Reviews in Uncontrolled Oncology Trials: A Comprehensive Review of the LiteratureFrontiers in Pharmacology 2022; 13 doi: 10.3389/fphar.2022.858354
15
Ketki S Dantkale, Manjusha Agrawal. A Comprehensive Review of Current Trends in the Diagnosis and Treatment of Ovarian Germ Cell TumorsCureus 2024;  doi: 10.7759/cureus.52650
16
Ewan Hunter, Matthew Salter, Ryan Powell, Ann Dring, Tarun Naithani, Maria Eleni Chatziioannou, Abel Gebregzabhar, Mutaz Issa, Jayne Green, Serene Ng, Chun Ren Lim, Cheah Soon Keat, Ang Tick Suan, Rakesh Raman, Ho Kean Fatt, Fabian Lee Wei Luen, Heba Alshaker, Dmitri Pchejetski, Dave Blum, Thomas Guiel, Robert Heaton, Jedd Levine, Alexandre Akoulitchev. Development and Validation of Blood-Based Predictive Biomarkers for Response to PD-1/PD-L1 Checkpoint Inhibitors: Evidence of a Universal Systemic Core of 3D Immunogenetic Profiling across Multiple Oncological IndicationsCancers 2023; 15(10): 2696 doi: 10.3390/cancers15102696
17
Daniel-Clement Osei-Bordom, Sivesh Kamarajah, Niki Christou. Colorectal Cancer, Liver Metastases and BiotherapiesBiomedicines 2021; 9(8): 894 doi: 10.3390/biomedicines9080894
18
Laura Schomburg, Amer Malouhi, Marc-Oliver Grimm, Maja Ingwersen, Susan Foller, Katharina Leucht, Ulf Teichgräber. iRECIST-based versus non-standardized free text reporting of CT scans for monitoring metastatic renal cell carcinoma: a retrospective comparisonJournal of Cancer Research and Clinical Oncology 2022; 148(8): 2003 doi: 10.1007/s00432-022-03997-0
19
Abhishek Mahajan, Nivedita Chakrabarty, Jinita Majithia, Ankita Ahuja, Ujjwal Agarwal, Shubham Suryavanshi, Mahesh Biradar, Prerit Sharma, Bagyam Raghavan, Rasheed Arafath, Shreya Shukla. Multisystem Imaging Recommendations/Guidelines: In the Pursuit of Precision OncologyIndian Journal of Medical and Paediatric Oncology 2023; 44(01): 002 doi: 10.1055/s-0043-1761266
20
Fanli Zhou, Zhidong Yuan, Xianglin Liu, Keyan Yu, Bowei Li, Xingyan Li, Xin Liu, Guanxun Cheng. Evaluation of atrial anatomical remodeling in atrial fibrillation with machine-learned morphological featuresInternational Journal of Computer Assisted Radiology and Surgery 2022; 18(4): 603 doi: 10.1007/s11548-022-02776-z
21
Maria Rosaria Ruggiero, Simona Baroni, Valeria Bitonto, Roberto Ruiu, Smeralda Rapisarda, Silvio Aime, Simonetta Geninatti Crich. Intracellular Water Lifetime as a Tumor Biomarker to Monitor Doxorubicin Treatment via FFC-Relaxometry in a Breast Cancer ModelFrontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.778823
22
Nicholas J. Schork, Laura H. Goetz, James Lowey, Jeffrey Trent. Strategies for Testing Intervention Matching Schemes in CancerClinical Pharmacology & Therapeutics 2020; 108(3): 542 doi: 10.1002/cpt.1947
23
Suji Udayakumar, Ambica Parmar, Natasha B. Leighl, Louis Everest, Vanessa S. Arciero, Seanthel Delos Santos, Amanda Rahmadian, Mark K. Doherty, Kelvin K.W. Chan. Pembrolizumab alone or with chemotherapy for metastatic non-small-cell lung cancer: A systematic review and network meta-analysisCritical Reviews in Oncology/Hematology 2022; 173: 103660 doi: 10.1016/j.critrevonc.2022.103660
24
Faruque Azam, Alexei Vazquez. Trends in Phase II Trials for Cancer TherapiesCancers 2021; 13(2): 178 doi: 10.3390/cancers13020178
25
Yong-Jin Park, Seung Hyup Hyun, Seung Hwan Moon, Kyung-Han Lee, Byung Hoon Min, Jun Haeng Lee, Won Seog Kim, Seok Jin Kim, Joon Young Choi. Role in staging and prognostic value of pretherapeutic F-18 FDG PET/CT in patients with gastric MALT lymphoma without high-grade transformationScientific Reports 2021; 11(1) doi: 10.1038/s41598-021-88815-2
26
Fangzhou He, Lu Xie, Xin Sun, Jie Xu, Yuan Li, Rong Liu, Kunkun Sun, Danhua Shen, Jin Gu, Tao Ji, Wei Guo. A Scoring System for Predicting Neoadjuvant Chemotherapy Response in Primary High‐Grade Bone Sarcomas: A Multicenter StudyOrthopaedic Surgery 2022; 14(10): 2499 doi: 10.1111/os.13469
27
Azadeh Tabari, Meredith Cox, Brian D’Amore, Arian Mansur, Harika Dabbara, Genevieve Boland, Michael S. Gee, Dania Daye. Machine Learning Improves the Prediction of Responses to Immune Checkpoint Inhibitors in Metastatic MelanomaCancers 2023; 15(10): 2700 doi: 10.3390/cancers15102700
28
Daniel Zeitouni, Michael P. Catalino, Jordan Wise, Sean McCabe, Kathryn Pietrosimone, Naim Rashid, Simon Khagi. Clinical Application of Next-Generation Sequencing in Recurrent GlioblastomaOnco 2021; 1(1): 38 doi: 10.3390/onco1010005
29
Qian-Yu Yang, Lin Zhu, Hong-Xia Liu, Qing-Shan Zheng, Lu-Jin Li. Quantitative comparison of the efficacies and safety profiles of three first-line non-platinum chemotherapy regimens for advanced non-small cell lung cancerFrontiers in Pharmacology 2022; 13 doi: 10.3389/fphar.2022.806728
30
Fang-Ying Chiu, Yun Yen. Imaging biomarkers for clinical applications in neuro-oncology: current status and future perspectivesBiomarker Research 2023; 11(1) doi: 10.1186/s40364-023-00476-7
31
Steffen Ventz, Leah Comment, Bill Louv, Rifaquat Rahman, Patrick Y Wen, Brian M Alexander, Lorenzo Trippa. The use of external control data for predictions and futility interim analyses in clinical trialsNeuro-Oncology 2022; 24(2): 247 doi: 10.1093/neuonc/noab141
32
Amani A. Alrehaili, Amal F. Gharib, Maha M. Bakhuraysah, Afaf Alharthi, Ohud Alsalmi, Fouzeyyah Ali Alsaeedi, Reem Ali Alhakami, Kamilah Ali Alasmari, Nuha Mohammed, Wael H. Elsawy. Serum Pro-Inflammatory Cytokines and Leptin as Potential Biomarkers for Treatment Response and Toxicity in Locally Advanced Squamous Cell Carcinoma of the Head and NeckDiseases 2024; 12(3): 55 doi: 10.3390/diseases12030055
33
Yuze Li, Ziming Xu, Chao An, Huijun Chen, Xiao Li. Multi-Task Deep Learning Approach for Simultaneous Objective Response Prediction and Tumor Segmentation in HCC Patients with Transarterial ChemoembolizationJournal of Personalized Medicine 2022; 12(2): 248 doi: 10.3390/jpm12020248
34
Ahmed Nassar, Amir Abdelhamid, George Ramsay, Mohamed Bekheit. Chronomodulated Administration of Chemotherapy in Advanced Colorectal Cancer: A Systematic Review and Meta-AnalysisCureus 2023;  doi: 10.7759/cureus.36522
35
Maria Isabella Donegani, Giulia Ferrarazzo, Stefano Marra, Alberto Miceli, Stefano Raffa, Matteo Bauckneht, Silvia Morbelli. Positron Emission Tomography-Based Response to Target and Immunotherapies in OncologyMedicina 2020; 56(8): 373 doi: 10.3390/medicina56080373
36
Cinzia Dello Russo, Natalia Cappoli, Daniela Pilunni, Pierluigi Navarra. Local Investigators Significantly Overestimate Overall Response Rates Compared to Blinded Independent Central Reviews in Phase 2 Oncology TrialsThe Journal of Clinical Pharmacology 2021; 61(6): 810 doi: 10.1002/jcph.1790
37
Adnan Ahmad, Mohammad Haneef, Shadma Khan, Fariya Khan, Nabeel Ahmad, Saif Khan, Samriddhi Jaswani. CAR T‑cell immunotherapy: A safe and potent living drug technique for cancer treatment (Review)World Academy of Sciences Journal 2023; 5(4) doi: 10.3892/wasj.2023.200
38
Nathan A. Pennell. Strategies and End Points in the Development of Novel Immunotherapy Trials for Patients With Unresectable, Locally Advanced Non–Small-Cell Lung CancerJournal of Clinical Oncology 2022; 40(29): 3353 doi: 10.1200/JCO.22.00827